Ichidai Tanaka

8PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 23, 2024
Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR-mutated non-small-cell lung cancer: a retrospective, multicenter cohort study.

Ichidai Tanaka, Kazumi Hori, Junji Koyama

|Feb 24, 2024
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma.

Mei-Chee Tai, Leonidas E Bantis, Gargy Parhy

|May 28, 2022
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma.

Johannes F Fahrmann, Ichidai Tanaka, Ehsan Irajizad

|Jan 11, 2022
Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations.

Ichidai Tanaka, Masahiro Morise

|Sep 15, 2021
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.

Ichidai Tanaka, Delphine Dayde, Mei Chee Tai

|Aug 27, 2021
The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intelligence.

Ichidai Tanaka, Taiki Furukawa, Masahiro Morise

Pageof 2

Frequent Collaborators

3 joint publications

Ayumu Taguchi

3 joint publications

Edwin J Ostrin

2 joint publications

Yoshinori Hasegawa

2 joint publications

Luisa Maren Solis Soto